Study Goal: The rational design and implementation of plans for triage of populations impacted by largescale radiation events necessarily includes consideration of sensitivity and specificity. This is best done using receiver operating characteristic (ROC) analyses with representative sample populations. The technique for generation of ROC curves for biodosimetry data will be presented along with representative ROC curves, summary statistics, and discussion.
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Abstract: ROC analysis is a fundamental tool used for the evaluation and comparison of screening systems that provides estimates of the combinations of sensitivity and specificity that can be achieved with a given technique. Along with critical considerations of practical limitations, such as throughput and time to availability of results, ROC analyses can be applied to provide meaningful assessments and comparisons of available biodosimetry methods. Accordingly, guidance from the FDA to evaluate biodosimetry devices recommends ROC analysis in part because other dosimetry metrics, such as minimum detectable dose and other summary statistics, do not adequately address the performance of these techniques as screening tools. However, most of the existing literature for the numerous biodosimetry methods that have been developed to address the needs for triage either do not contain ROC analyses or present ROC analyses where the dose distributions of the study samples are not representative of the populations to be screened. The use of nonrepresentative sample populations can result in a significant spectrum bias, where the estimated performance does not accurately characterize the true performance under real world conditions. Direct data under these conditions do not exist, but a number of complex simulations have been performed and reported in the literature that do provide the required distribution estimates.
Conclusion:
Based on these simulations and reported data about the output of biodosimetry methods, we generated ROC curves to compare biodosimetry techniques (e.g., EPR tooth, Dicentric Chromosome Assay, CBMN, qPCR assays). We assert that this methodology should be adopted generally for characterization of radiation biodosimetry screening assays.
